{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:13:46Z","timestamp":1791764026922,"version":"4.3.4"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000262","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>We describe a novel colopathy associated with pentosan polysulfate (PPS) use and assess the strength of the drug-disease association in a two-part investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>1. Cohort Study: We studied individuals with a history of long-term PPS use. Case histories concerning gastrointestinal disease were obtained with review of endoscopy records and histopathology specimens. Findings were summarized with descriptive statistics. 2. Cross-Sectional Study: We evaluated patients with interstitial cystitis at a single clinical center. We obtained data on drug exposure and medical histories and measured the strength of association between PPS use and diagnosis of inflammatory bowel disease (IBD) using multivariate logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>1. Cohort Study: Among 13 participants, the median PPS exposure was 2.04\u00a0kg (range 0.99\u20132.54\u00a0kg). Eleven participants (84.6%) developed IBD symptomatology after initiating PPS therapy, and 9 (69.2%) were diagnosed with IBD. Two others (18%) were diagnosed with irritable bowel syndrome. Of the 10 participants with endoscopic and histopathologic data, six had abnormal colonic mucosa on endoscopy, and all 10 had histologic abnormalities. Clinical and histologic improvement was noted after PPS cessation, though two (18%) required colectomy for colitis-associated dysplasia. 2. Cross-Sectional Study: Among 219 subjects with interstitial cystitis, PPS use was a statistically significant predictor of an IBD diagnosis, with an adjusted odds ratio of 3.3 (95% confidence interval, 1.2\u20138.8, p = 0.02).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Our study identifies a strong association between PPS use and clinical diagnosis of IBD. Histopathologic findings suggest a novel drug-associated colopathy, with some subjects necessitating colectomy for dysplasia. Further investigation into the causality of this association is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1494467","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T05:30:58Z","timestamp":1753680658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Colopathy associated with pentosan polysulfate use"],"prefix":"10.3389","volume":"16","author":[{"given":"Emily H.","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namita E.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin I.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azhar","family":"Nizam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Iskandar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nieraj","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/s0090-4295(99)80332-x","article-title":"Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes","volume":"49","author":"Alagiri","year":"1997","journal-title":"Urology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.14309\/ajg.0000000000002137","article-title":"Pentosan polysulfate-associated dysplasia in patients with inflammatory bowel disease: a case series","volume":"118","author":"Anderson","year":"2022","journal-title":"Am. J. Gastroenterol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202010732","article-title":"Engineered sulfated polysaccharides for biomedical applications","volume":"31","author":"Arlov","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"B4","doi-asserted-by":"publisher","first-page":"15.25.1","DOI":"10.1002\/0471142735.im1525s104","article-title":"Dextran sulfate sodium (DSS)-induced colitis in mice","volume":"104","author":"Chassaing","year":"2014","journal-title":"Curr. Protoc. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/JU.0000000000002756","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome","volume":"208","author":"Clemens","year":"2022","journal-title":"J. Urol."},{"key":"B6","first-page":"238","article-title":"Clinicopathologic study of dextran sulfate sodium experimental murine colitis","volume":"69","author":"Cooper","year":"1993","journal-title":"Lab. Invest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/14656566.2018.1491968","article-title":"An evaluation of the pharmacotherapy for interstitial cystitis","volume":"19","author":"Giusto","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"B8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ajo.2024.12.004","article-title":"Pentosan polysulfate maculopathy: final outcomes from a 4-year prospective study of disease progression after drug cessation","volume":"271","author":"Hall","year":"2025","journal-title":"Am. J. Ophthalmol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.cgh.2020.04.069","article-title":"Drug-induced colitis","volume":"19","author":"Hamdeh","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.ophtha.2019.04.024","article-title":"Strength of association between pentosan polysulfate and a novel maculopathy","volume":"126","author":"Hanif","year":"2019","journal-title":"Ophthalmology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3109\/10408448709071209","article-title":"Induction of colorectal tumors in rats by sulfated polysaccharides","volume":"17","author":"Ishioka","year":"1987","journal-title":"Crit. Rev. Toxicol."},{"key":"B12","volume-title":"Elmiron (pentosan polysulfate sodium) [package insert]","year":"2021"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1101\/2023.04.03.23288071","volume-title":"Colopathy associated with pentosan polysulfate use","author":"Jung","year":"2023"},{"key":"B14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jcmgh.2015.01.006","article-title":"Experimental models of inflammatory bowel diseases","volume":"1","author":"Kiesler","year":"2015","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0094-0143(21)00587-5","article-title":"Epidemiology of interstitial cystitis","volume":"21","author":"Koziol","year":"1994","journal-title":"Urol. Clin. North Am."},{"key":"B16","first-page":"2347","article-title":"Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer","volume":"3","author":"Marshall","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ogc.2014.05.004","article-title":"Interstitial cystitis: epidemiology, pathophysiology, and clinical presentation","volume":"41","author":"McLennan","year":"2014","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"B18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.urology.2004.10.071","article-title":"Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis","volume":"65","author":"Nickel","year":"2005","journal-title":"Urology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.ophtha.2018.04.026","article-title":"Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium","volume":"125","author":"Pearce","year":"2018","journal-title":"Ophthalmology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/00365590310008721","article-title":"Intercurrent autoimmune conditions in classic and non-ulcer interstitial cystitis","volume":"37","author":"Peeker","year":"2003","journal-title":"Scand. J. Urol. Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1046\/j.1365-2125.2003.01980.x","article-title":"Pathology of drug-associated gastrointestinal disease","volume":"56","author":"Price","year":"2003","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/bf02235589","article-title":"Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon","volume":"43","author":"P\u00fcsp\u00f6k","year":"2000","journal-title":"Dis. Colon Rectum"},{"key":"B23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.survophthal.2024.12.002","article-title":"Pentosan polysulfate sodium maculopathy: final analysis of a prospective cohort, updated review, and association with inflammatory bowel disease","volume":"70","author":"Santina","year":"2025","journal-title":"Surv. Ophthalmol."},{"key":"B24","unstructured":"A statistical and medical review of an amendment to the new drug application for elmiron (pentosan polysulfate)\n          \n          \n          1996"},{"key":"B25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.tifs.2018.02.010","article-title":"Sulfated modification of polysaccharides: synthesis, characterization and bioactivities. Trends in food science & technology","volume":"1","author":"Wang","year":"2018","journal-title":"Apri"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1494467\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T05:31:00Z","timestamp":1753680660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1494467\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":25,"alternative-id":["10.3389\/fphar.2025.1494467"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1494467","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.03.23288071","asserted-by":"object"}]},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"article-number":"1494467"}}